Keurig Dr Pepper stock eases after insider sale as 2026 guidance stays intact
Published on 09/11/2026 at 15:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Keurig Dr Pepper stock (ISIN US49271V1008) closed at USD 31.46 on Nasdaq on September 10, 2026, down 1.9 percent from the previous session, as investor attention shifted to insider selling and upcoming corporate changes.
Insider sale and Chobani exit shape sentiment
According to Investing.com on September 11, 2026, Chief Human Resources Officer Mary Beth DeNooyer sold a total of 24,000 Keurig Dr Pepper shares across September 8 and September 9, 2026, generating proceeds of USD 778,199 at weighted average prices of USD 32.55 and USD 32.30 per share.
Detailed Form 4 data show that DeNooyer sold 12,000 shares at a weighted average price of USD 32.55 on September 8, 2026 and another 12,000 shares at USD 32.30 on September 9, 2026, with trade prices ranging from USD 32.41 to USD 32.63 and from USD 31.99 to USD 32.64 respectively, according to StockTitan.
The insider transactions come as Keurig Dr Pepper monetizes its minority stake in yogurt maker Chobani, with divestment proceeds expected to total about USD 925 million, including roughly USD 800 million from the sale transaction and an earlier preferred payout, as Yahoo Finance reported on September 11, 2026.
Guidance for 2026 and transformation plan
At the Barclays 19th Annual Global Consumer Staples Conference on September 10, 2026, Keurig Dr Pepper reaffirmed its full-year 2026 guidance, projecting revenue between USD 25.9 billion and USD 26.4 billion, which includes legacy Keurig Dr Pepper growth of 4 percent to 6 percent and an additional USD 8.5 billion to USD 8.7 billion contribution from JDE Peet’s for nine months of ownership, according to Investing.com.
The company also guided for low double-digit constant-currency EPS growth in 2026, underpinned by legacy operations contributing 4 percent to 6 percent EPS growth and an additional six to seven percentage points of accretion from the JDE Peet’s acquisition, as highlighted in the same Barclays conference transcript from Investing.com.
In addition, Keurig Dr Pepper is targeting USD 2.5 billion of free cash flow for 2026 to support deleveraging, with levered free cash flow over the last twelve months already reaching USD 1.97 billion, providing visibility on its ability to fund the transformation plan and maintain shareholder returns, according to the same Barclays conference coverage by Investing.com.
Analyst view and valuation context
Per data compiled by MarketBeat as of September 11, 2026, Keurig Dr Pepper stock carries a consensus rating of Moderate Buy based on 11 buy and 8 hold recommendations, with an average price target of USD 34.94, implying roughly 11.1 percent upside from the recent price of USD 31.46.
The same overview from MarketBeat shows a 52-week trading range between USD 24.88 and USD 33.82, placing the September 10, 2026 close of USD 31.46 around 7 percent below the 52-week high and well above the low, and a market capitalization of USD 42.81 billion at that level.
From a valuation perspective, Keurig Dr Pepper’s price-to-earnings ratio stands at 31.78 and its dividend yield at 2.92 percent as of the same MarketBeat dataset, indicating that the stock offers a mix of growth and income characteristics compared with broader consumer staples peers, according to MarketBeat.
Stock level and trading data
At the close on September 10, 2026, Keurig Dr Pepper stock finished at USD 31.46 on Nasdaq after falling 1.9 percent, with a trading volume of about 10.45 million shares compared with an average of 11.85 million shares, according to MarketBeat.
Keurig Dr Pepper stock at a glance
- Company: Keurig Dr Pepper Inc.
- ISIN: US49271V1008
- Ticker: KDP
- Trading venue: Nasdaq
- Price (as of September 10, 2026, 4:00): 31.46 USD
- Market capitalization: 42.81 billion USD (as of September 10, 2026)
- Sector / Industry: Consumer Staples / Beverages
- Index membership: S&P 500
